GovWire

Company led medicines recall: Mawdsley-Brooks & Company Limited, Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection, CLMR(23)A/01

Medicines Healthcare Products Regulatory Agency

January 12
14:05 2023

CLMR Number

CLMR(23)A/01

MDR Number

MDR 234-11/22

Company name

Mawdsley-Brooks & Company Limited

Product description

Fluphenazin-neuraxpharm D 100 mg/ml Solution for Injection [unlicensed medicine]

Batch Number Expiry Date Pack Size First Distributed
200686 01/2024 5 x 1ml 21/05/2021

Active ingredient: Fluphenazine

Fluphenazin-neuraxpharm D 25 mg/ml Solution for Injection [unlicensed medicine]

Batch Number Expiry Date Pack Size First Distributed
202052 01/2024 5 x 1ml 16/07/2021

Active ingredient: Fluphenazine

Brief Description of Problem

Specific batches of product are recalled as a precautionary measure due to validation tests demonstrating the leaching of filter additives that are above the acceptable limit.

This recall is being issued as a company-led medicines recall as the products are only supplied to limited number of customers, and the manufacturer has full traceability of the products distribution.

Remaining stock of the above batches should be quarantined and returned to Mawdsleys directly.

Company Contact for medical information enquiries

For medical information enquiries, please contact Michelle Biggs at michelle.biggs@mawdsleys.co.uk

Company Contact for stock enquiries

For stock information enquiries, please contact Andrea Dunlop at andrea.dunlop@mawdsleys.co.uk

Published 12 January 2023

Related Articles

Scroll Back To Top 📄More Articles

Comments

Scroll Back To Top Write Comment
  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Scroll Back To Top
Your name:
Your email:
Comments:

Post my comment

News Calendar

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: